IMMX

Immix Biopharma, Inc. IMMX

IMMX
Immix Biopharma, Inc. COYA
Coya Therapeutics, Inc. WHWK
Whitehawk Therapeutics Inc ONCY
Oncolytics Biotech Inc. ZNTL
Zentalis Pharmaceuticals, Inc. SRZN
Surrozen, Inc. ATOS
Atossa Therapeutics, Inc. TIL
Instil Bio, Inc. PLRX
Pliant Therapeutics, Inc. MGNX
MacroGenics, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode IMMX COYA WHWK ONCY ZNTL SRZN ATOS TIL PLRX MGNX
6M 171.91 % 8.70 % 23.98 % 60.20 % 3.36 % 146.26 % -7.89 % -67.92 % -11.96 % -7.89 %
YTD 190.45 % 7.18 % -22.61 % 4.75 % -53.83 % 63.82 % -20.32 % -49.21 % -90.85 % -57.58 %
1Y 227.69 % 8.13 % 2.10 % 18.06 % -55.32 % 133.45 % -28.50 % -51.20 % -91.14 % -56.66 %
3Y 224.37 % 33.92 % -80.87 % -46.78 % -92.85 % 224.10 % 29.66 % -5.33 % -93.74 % -77.31 %
5Y 74.11 % 33.92 % -85.79 % -59.75 % -97.39 % -84.61 % -13.07 % -97.92 % -95.78 % -94.34 %
10Y 74.11 % 33.92 % -97.30 % -68.98 % -94.03 % -84.61 % -98.79 % -97.92 % -94.30 % -95.34 %
From the beginning 74.11 % 33.92 % -97.30 % -98.01 % -94.03 % -84.61 % -99.91 % -97.92 % -94.30 % -94.40 %

Dividend